China's Sichuan Xieli Pharmaceutical fined for obstructing antitrust probe
MLex Summary: China's Sichuan Xieli Pharmaceutical Company has been fined 2,790,700 yuan ($389,000) — equivalent to 0.8 percent of its 2022 sales — by the Jiangsu Provincial Market Regulator for violently...To view the full article, register now.
Already a subscriber? Click here to view full article